Elekta AB (EKTAY)
Elekta Market Cap: 2.914B for May 17, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 17, 2024 | 2.914B |
May 16, 2024 | 2.931B |
May 15, 2024 | 2.911B |
May 14, 2024 | 2.871B |
May 13, 2024 | 2.854B |
May 10, 2024 | 2.814B |
May 09, 2024 | 2.734B |
May 08, 2024 | 2.769B |
May 07, 2024 | 2.772B |
May 06, 2024 | 2.778B |
May 03, 2024 | 2.701B |
May 02, 2024 | 2.684B |
May 01, 2024 | 2.689B |
April 30, 2024 | 2.755B |
April 29, 2024 | 2.738B |
April 26, 2024 | 2.619B |
April 25, 2024 | 2.560B |
April 24, 2024 | 2.644B |
April 23, 2024 | 2.694B |
April 22, 2024 | 2.650B |
April 19, 2024 | 2.571B |
April 18, 2024 | 2.589B |
April 17, 2024 | 2.625B |
April 16, 2024 | 2.663B |
April 15, 2024 | 2.709B |
Date | Value |
---|---|
April 12, 2024 | 2.682B |
April 11, 2024 | 2.795B |
April 10, 2024 | 2.827B |
April 09, 2024 | 2.911B |
April 08, 2024 | 2.987B |
April 05, 2024 | 2.929B |
April 04, 2024 | 2.957B |
April 03, 2024 | 2.982B |
April 02, 2024 | 2.928B |
April 01, 2024 | 2.895B |
March 28, 2024 | 2.869B |
March 27, 2024 | 2.892B |
March 26, 2024 | 2.890B |
March 25, 2024 | 2.893B |
March 22, 2024 | 2.877B |
March 21, 2024 | 2.879B |
March 20, 2024 | 2.864B |
March 19, 2024 | 2.889B |
March 18, 2024 | 2.869B |
March 15, 2024 | 2.917B |
March 14, 2024 | 2.871B |
March 13, 2024 | 2.871B |
March 12, 2024 | 2.878B |
March 11, 2024 | 2.828B |
March 08, 2024 | 2.840B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
Abliva AB | 13.44M |
Karolinska Development AB | 69.51M |
Calliditas Therapeutics AB | 595.49M |
Oncopeptides AB | 23.97M |
Olink Holding AB | 2.978B |
Market Cap Related Metrics
PE Ratio | 21.48 |
PS Ratio | 1.694 |
PEG Ratio | 0.3282 |
Price to Book Value | 2.959 |
Price to Free Cash Flow | 20.07 |
Price | 7.627 |
Earnings Yield | 4.66% |
PEGY Ratio | 0.314 |
Operating PE Ratio | 12.46 |
Normalized PE Ratio | 21.48 |